Allarity Therapeutics Inc (NASDAQ:ALLR) has a beta value of 0.35 and has seen 5.58 million shares traded in the last trading session. The company, currently valued at $6.03M, closed the last trade at $1.36 per share which meant it gained $0.04 on the day or 3.03% during that session. The ALLR stock price is -21076.47% off its 52-week high price of $288.00 and 33.82% above the 52-week low of $0.90. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.39 million shares traded. The 3-month trading volume is 1.18 million shares.
The consensus among analysts is that Allarity Therapeutics Inc (ALLR) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
Allarity Therapeutics Inc (NASDAQ:ALLR) trade information
Sporting 3.03% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ALLR stock price touched $1.36 or saw a rise of 11.69%. Year-to-date, Allarity Therapeutics Inc shares have moved 16.24%, while the 5-day performance has seen it change 32.04%. Over the past 30 days, the shares of Allarity Therapeutics Inc (NASDAQ:ALLR) have changed 37.36%. Short interest in the company has seen 0.18 million shares shorted with days to cover at 0.3.
Allarity Therapeutics Inc (ALLR) estimates and forecasts
Figures show that Allarity Therapeutics Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -74.63% over the past 6 months, with this year growth rate of 98.73%, compared to 16.40% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 57.56% over the past 5 years.
ALLR Dividends
Allarity Therapeutics Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Allarity Therapeutics Inc (NASDAQ:ALLR)’s Major holders
Insiders own 12.32% of the company shares, while shares held by institutions stand at 2.21% with a share float percentage of 2.52%. Investors are also buoyed by the number of investors in a company, with Allarity Therapeutics Inc having a total of 5.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund . As of Nov 30, 2024 , the former fund manager holds about 0.16% shares in the company for having 7.19 shares of worth $9781.0 while later fund manager owns 1.93 shares of worth $2630.0 as of Nov 30, 2024 , which makes it owner of about 0.04% of company’s outstanding stock.
